John Kingdom

Dr. Kingdom established and co-directed the Placenta Program with his colleague Dr. Rory Windrim in the Maternal-Fetal Medicine Division at Mount Sinai Hospital, since 1999. This is an interdisciplinary clinical-research program, supporting basic, translational and clinical research in all aspects of Placental diseases. His research is currently funded by the Canadian Institutes of Health Research (since 2003), the National Institutes of Health, USA, the Alva Foundation, Canada and several grateful donors. He has previously been funded by the Ontario Physicians' Services Incorporated Foundation and the Alternate Funding Plan Innovation Fund of Mount Sinai Hospital-University Health Network. In addition to his research interests, Dr. Kingdom has a focus on junior faculty membership and career development.

Career Development

Medical School: Trinity College, Dublin, Ireland (1984)

Residency in Pediatrics: University of Glasgow, Scotland (-1987)

Residency in Obstetrics & Gynaecology: University of Glasgow, Scotland (-1994)

Clinician Investigator Program (MRC, UK): University of Glasgow, Scotland, (1990-1992)

Fellowship in Maternal-Fetal Medicine: University College London, England (-1995)

Castellucci Prize, European Placenta Group (1997)

Senior Lecturer in Obstetrics & MFM: University College Hospital, London, England (-1998)

Staff MFM Physician, Mount Sinai Hospital, University of Toronto, Canada (-present)

Inaugural Rose Torno Chair in OBGYN, Mount Sinai Hospital (2005-2016)

Professor of OBGYN, University of Toronto, Canada (2005-present)

President, Perinatal Research Society (2011)

Head, Division of MFM, University of Toronto, Canada (2012-2013)

Chair, Department of OBGYN, University of Toronto (2013-present)

Selected list of publications

1. McLaughlin K, Drewlo S, Parker J, Kingdom J. (2015). Current theories on the prevention of severe-preeclampsia with low-molecular weight heparin. Hypertension. 66(6): 1098-103.

2. Wald RM, Silversides CK, Kingdom J, Toi A, Lau CS, Mason J, Colman JM, Sermer M, Siu SC.(2015). Maternal Cardiac Output and Fetal Doppler Predict Adverse Neonatal Outcomes in Pregnant WomenWith Heart Disease.J Am Heart Assoc. 4(11): pii: e002414.

3. Zhu MY, Milligan N, Keating S, Windrim R, Keunen J, Thakur V, Ohman A, Portnoy S, Sled JG, Kelly E, Yoo SJ, Gross-Wortmann L, Jaeggi E, Macgowan CK, Kingdom JC, Seed M.(2015). The hemodynamics of late onset intrauterine growth restriction by MRI.Am J Obstet Gynecol. S0002-9378(15): 01267-3.

4. Mäkikallio K, Shah J, Slorach C, Qin H, Kingdom J, Keating S, Kelly E, Manlhiot C, Redington A, Jaeggi E.(2015). Fetal growth restriction and cardiovascular outcome in early human infancy: a prospective longitudinal study.Heart and Vessels. 19: Epub ahead of print.

5. Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, Grosse-Wortmann L, Jaeggi E, McCrindle BW, Kingdom J, Hickey E, Miller S, Seed M. (2015). Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease.Circulation. 131(15): 1313-23.

6. Melamed N, Ray JG, Shah PS, Berger H, Kingdom JC. (2014). Should we use customized fetal growth percentiles in urban Canada. J Obstet Gynaecol Can. 36(2): 164-70.

7. Porat S , Fitzgerald B , Wright E , Keating S , Kingdom JC. (2013). Placental Hyperinflation and the Risk of Adverse Perinatal Outcome.Ultrasound Obstet Gynecol. 42(3): 315-21.

8. Lausman A, Kingdom J.(2013). Intrauterine growth restriction: screening, diagnosis and management.Journal of Obstetrics and Gynaecology, Canada. 35(8): 741-748.

9. Bhide A , Acharya G , Bilardo CM , Brezinka C , Cafici D , Hernandez-Andrade E , Kalache K , Kingdom J , Kiserud T , Lee W , Lees C , Leung KY , Malinger G , Mari G , Prefumo F , Sepulveda W , Trudinger B. (2013). ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics.Ultrasound inobstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 41(2): 233-39.

10. Walker MG , Fitzgerald B , Keating S , Ray JG , Windrim R , Kingdom JC. (2012). Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery.Placenta. 33(7): 568-71.